Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCOPE study: Tiotropium + olodaterol vs tiotropium in maintenance-naive Japanese COPD patients
jRCTs071180021Completed
- Sponsor
- Nippon Boehringer Ingelheim
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of tiotropium + olodaterol in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Nippon Boehringer Ingelheim. Primary endpoint: Forced expiratory volume in 1 second at 12 weeks. Started Jul 2017; status: completed.
02
Drugs
tiotropium + olodaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on jRCTs071180021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071180021.